Atorvastatin to Treat Pulmonary Sarcoidosis

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Sarcoidosis, Pulmonary
Interventions
DRUG

Atorvastatin

Placebo vs. Atorvastatin

OTHER

Placebo Oral Tablet

Placebo: Sham Therapy in an oral tablet formulation

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00279708 - Atorvastatin to Treat Pulmonary Sarcoidosis | Biotech Hunter | Biotech Hunter